Clinical Trial Update: TOCILIZUMAB IN FIBROUS DYSPLASIA OF BONE [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating tocilizumab for fibrous dysplasia of bone has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibrous Dysplasia of Bone

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Fibrous Dysplasia of Bone | Phase 2 | Status: COMPLETED